The intelligence layer for surgery. Every operation is already on video - Theator makes the video mean something.
THE HOUSE STYLE. A wordmark, a dusk-blue mountain, and a promise you can argue with: that in the operating room, the receipts should outrank the memory.
Here is a fact about surgery that should bother you more than it does: almost every minimally invasive operation is filmed, in crisp high definition, and then almost none of that footage is ever looked at again. The camera records, the case ends, the file sits on a drive, and the surgeon writes up what happened from memory a few hours later. Billions of hours of the highest-stakes video in medicine, and the standard workflow treats it like a security tape at a gas station - kept, technically, in case someone asks.
Theator's founders looked at that and saw not a storage problem but a data problem, which is a more interesting kind of problem because data problems have upside. The company was started in 2018 by Dr. Tamir Wolf, a physician, and Dotan Asselmann, an engineer, on a premise that sounds obvious once you say it out loud: if you could actually read the video - identify each step, flag the safety-critical moments, note when things deviate - surgery would finally have the thing it strangely lacks, which is a feedback loop.
The origin story is the kind that founders retell because it happens to be true. In 2015, Wolf's wife had an emergency appendectomy in one New York hospital and was home in twelve hours. Around the same time, his boss had the same operation, same diagnosis, same city, and ended up in the ICU nearly dying. Same problem, wildly different outcome, and no systematic way to explain why. That gap - surgeons call it variability - is the thing Theator exists to shrink.
The unglamorous truth is that you cannot improve what you do not measure, and surgery, for all its precision, has historically been measured about as well as a restaurant is measured by whether anyone got food poisoning. Theator's bet is that the measurement was always available. It was just sitting in a video file nobody watched.
"All minimally invasive procedures are already visualized. We turn that video into intelligence."
— Theator, on its whole reason for existing
Strip away the category language and the platform does one legible thing: it watches surgery the way a very attentive resident would, except it never blinks, never forgets, and finishes its notes before the surgeon reaches the hallway.
A computer-vision engine reads the raw HD video feed in real time, identifies surgical milestones, tracks safety events, and produces a structured operative report - available by the time the surgeon leaves the OR, and more complete than one written from memory hours later.
The cloud platform captures, manages, de-identifies, and analyzes surgical video, giving surgeons replay, annotation, benchmarking against peers, and analytics from pre-op prep through post-op review - the full case, at any angle.
AI-generated reports flow straight into the electronic health record - including Oracle Health - so care teams, quality reviewers, and billing staff see them instantly. Fewer coding gaps; a financial record that reflects the real complexity of the case.
Watch it work. Product walk-throughs, founder talks and surgical-AI demos live on Theator's site and channels.
Platform Overview →The physician of the pair. He carried the founding grievance - the two appendectomies - into a company, and he tends to frame surgical variability as a solvable measurement problem rather than an unavoidable fact of medicine.
The engineer of the pair. His domain is the hard part: teaching computer-vision models to reliably read messy, high-definition intraoperative video and run some of the more compute-intensive AI workloads in healthcare.
Two near-identical appendectomies in New York end very differently. The variability becomes a founder's obsession.
Wolf and Asselmann start the company in Israel to turn surgical video into intelligence.
A $15.5M round lands, with Mayo Clinic in as both investor and deployment partner.
Insight Partners leads a $24M add-on, taking the round to ~$39.5M to expand across North America.
Surgery-to-Text reports route into the EHR via Oracle Cloud Infrastructure - AI in the OR, at customer scale.
| Round | Amount | Date |
|---|---|---|
| Seed | ~$3M | 2019 |
| Series A | $15.5M | Feb 2021 |
| Series A ext. | $24M | Jul 2022 |
Series A total ~$39.5M · lifetime funding est. ~$60-70M.
Backers include Insight Partners (lead), Blumberg Capital, Mayo Clinic, NFX, StageOne Ventures, iAngels and iCON - plus angels like former Netflix product chief Neil Hunt. Mayo Clinic writing a check and installing the product is the kind of dual signal a healthcare startup lives for.
Theator's platform is deployed at teaching hospitals and health systems - the places that already care about measuring themselves. In the US that includes Mayo Clinic and University of Miami Health; internationally, McGill University Health Centre, Assuta Medical Center and Prisma Health. The business model is straightforward B2B SaaS: sell the platform to health systems, tie the value to documentation automation, quality improvement, and less variability - which conveniently is both a clinical win and a billing win.
Replay and benchmark your own cases, review the safety-critical moments, and skip writing the operative note by hand.
Fewer coding gaps, more accurate operative records, and a data feedback loop for quality improvement across the OR.
The quiet payoff: care that varies a little less depending on which surgeon, which hospital, which day.
There is a version of "AI in surgery" that makes people nervous, and it involves a robot holding the scalpel. Theator built the other version, the one that is much harder to object to: AI as a set of eyes that never blink and a scribe that never misremembers. It does not take the surgeon's job. It takes the surgeon's paperwork, which the surgeon was never especially fond of anyway.
That framing is also, not coincidentally, good business. Most healthcare AI dies in the pilot phase because it solves a problem nobody with a budget feels. Incomplete operative reports, on the other hand, are a problem a hospital feels in dollars - coding gaps, under-captured complexity, lost reimbursement. Theator built a clinical product with a CFO-shaped hole it fits into. The mission is variability; the invoice is documentation.
The competitive field is real - Caresyntax, Proximie, Activ Surgical, Surgical Safety Technologies and the device-makers' own analytics are all circling the operating room. But the Oracle Health deal is the tell. The unsexy part of medical AI is not the model, it's the integration, and getting your output to land inside the EHR where billing and quality staff already live is how a demo becomes a workflow. Boring plumbing is often how the interesting technology actually reaches a patient.
1. The whole company traces back to two emergency appendectomies in New York in 2015 - same city, same diagnosis, opposite outcomes.
2. The tagline "data beats intuition" isn't marketing garnish - it's basically the entire thesis in three words.
3. Theator likes an aviation analogy: train and debrief surgeons the way airlines train and review pilots, with replay and data.
4. Nearly every minimally invasive surgery is already filmed. The founding insight was simply that the footage was never analyzed.
5. Former Netflix Chief Product Officer Neil Hunt is on the cap table - a recommendation-engine guy backing a video-intelligence company.
It's a surgical intelligence platform that uses computer vision and AI to analyze operating-room video in real time - identifying surgical steps and safety milestones and automatically generating structured operative reports.
Dr. Tamir Wolf (CEO) and Dotan Asselmann (CTO) founded it in 2018, originally in Israel. It's now headquartered in Palo Alto, California.
Theator's flagship engine. It analyzes high-definition intraoperative video and produces an accurate, structured operative report by the time the surgeon leaves the operating room.
Customers include Mayo Clinic, University of Miami Health System, McGill University Health Centre, Assuta Medical Center and Prisma Health - with more than 600,000 procedures analyzed to date.
Roughly $60-70M across seed and Series A rounds, with the Series A (including a 2022 extension) totaling about $39.5M, led by Insight Partners.